The opportunity to present new ideas and original research in dermatology to Dermatology Refresher Symposium™ for NPs and PAs attendees is an integral part of the conference’s continuing medical education program. Encore abstracts/posters are permitted. This posters will be on display in the conference meeting space on poster boards and will be listed on the DRS website until December 31, 2023.
Poster submission is a 2-step process:
All abstracts will be submitted electronically via the Dermatology Refresher Symposium™ for NPs and PAs website. Send an abstract of the study by April 7, 2023, which will be reviewed and accepted based on scientific value and educational need. Abstracts may only be submitted by PAs, NPs, dermatologists, dermatology residents and dermatology researchers at universities, medical schools or industry. Students can submit an abstract for an e-poster only.
If approved, poster submissions of approved abstracts are electronically due on April 14, 2023.
There will be a break with poster authors on Saturday, April 22 from 9:45 am - 10:30 am. At least one author for each poster must be present and next to the poster during this break.
Abstract Submission Rules & Guidelines Submission deadline: 11:59pm Pacific Time on April 7, 2023. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $675 per abstract. The fee for e-posters for students is $50. Each abstract must be submitted separately. There is no limit on the number of abstracts a company may submit. Payment is required upon submission of this form. The fee is non- refundable unless your abstract is not accepted, in which case you will receive a full refund.
Format: Abstracts must be submitted as .pdf documents on the DRS website (www.dermrefoundation.org).
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 500 words max. inclusive of title, author and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation owns copyright for its own use. Author(s) retain the rights for all other uses. Please allow up to one week from date of submission for notification of approval or denial.
Pricing is available if interested in additional features such as uploading to the DRS website: audio slides, audio files/commentaries, or author videos of presentations.